Designing and executing a robust feasibility in rare disease clinical trials
In our new whitepaper, Designing and executing a robust feasibility in rare disease clinical trials, we explore critical factors that should be taken into consideration when conducting feasibilities.
What’s Inside:
- Data review, epidemiology and patient identification alongside other pointers that will support the decision-making process with respect to narrowing the country selection and tailoring the feasibility according to protocol requirements.
- Site and investigator selection, including site infrastructure, patient recruitment and retention and data mining and undiagnosed patients. If you have any questions while reading this whitepaper or would like additional information on orphan reach’s expertise, feel free to request a consultation.